Arctic Bioscience AS Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-41.03	-47.93	-45.51	-34.02	-42.58
Depreciation & Amortization	2.86	5.15	5.38	3.73	2.52
Other Amortization	2.26	-	-	-	-
Loss (Gain) From Sale of Assets	-0.01	-0.01	-	-	-
Other Operating Activities	0	-	-	-0	-
Change in Accounts Receivable	4.37	-5	3.91	-5.77	3.3
Change in Inventory	-0.64	3.81	2.67	-6.94	-2.28
Change in Accounts Payable	10.47	-0.78	2.82	9.89	-1.57
Change in Other Net Operating Assets	-0.94	-0.58	0.37	7.71	1.12
Operating Cash Flow	-22.65	-45.36	-30.37	-25.4	-39.49
Capital Expenditures	-22.75	-50.81	-34.7	-58.57	-36.5
Sale of Property, Plant & Equipment	0.05	0.18	2.23	-	-
Investing Cash Flow	-22.7	-50.63	-32.47	-58.57	-36.5
Long-Term Debt Issued	43.99	20.24	-	-	-
Total Debt Issued	43.99	20.24	-	-	-
Short-Term Debt Repaid	-	-	-	-	-1.88
Long-Term Debt Repaid	-0.63	-0.58	-2.2	-	-6.58
Total Debt Repaid	-0.63	-0.58	-2.2	-	-8.45
Net Debt Issued (Repaid)	43.36	19.66	-2.2	-	-8.45
Issuance of Common Stock	-	-	0.49	0.75	299.21
Financing Cash Flow	43.36	19.66	-1.71	0.75	290.76
Net Cash Flow	-1.99	-76.32	-64.55	-83.21	214.76
Free Cash Flow	-45.4	-96.17	-65.07	-83.96	-76
Free Cash Flow Margin	-106.53%	-216.64%	-192.81%	-243.58%	-353.22%
Free Cash Flow Per Share	-1.68	-3.79	-2.56	-3.43	-3.12
Levered Free Cash Flow	-36.09	-69.45	-60.47	-71.64	-58.59
Unlevered Free Cash Flow	-30.41	-67.48	-59.85	-71.64	-58.38
Change in Working Capital	13.26	-2.56	9.76	4.9	0.57